3628 results for «328»
3628 results
Nightmare in mitral valve interventions: sharing solutions together
18 Feb 2024 – From PCR Tokyo Valves 2024
This selection of cases showcase nightmare scenarios during mitral valve interventions. Find out what difficulties might arise during MitraClip procedure, and learn how to prevent complications through optimal treatments and bailouts.
New devices for aortic intervention
18 Feb 2024 – From PCR Tokyo Valves 2024
In this session, discover a variety of abstract submissions concerning new devices for aortic intervention. Compare the clinical outcomes of the latest intra-annular devices, examine the differences in debris between SEV and PEV, and learn about PVL improvement after TAVI with a self-expanding valve.
Rapid-fire - Bailout in TAVI
18 Feb 2024 – From PCR Tokyo Valves 2024
As TAVI is never risk-free, learn about bailout techniques to counter various complications through this series of rapid-fire case submissions. This session explores cases such as a transcatheter aortic valve distortion following cardiopulmonary resuscitation, acute transcatheter aortic valve migration into the left ventricle, and valve embolization.
30 years of primary PCI – a tale of perseverance
16 May 2023
Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
The impact of COVID-19 pandemic on interventional cardiologists in training
23 Oct 2020
In collaboration with EuroIntervention Journal
The authors decided to create a survey tailored for ICTs in order to assess the changes in their training. Capturing the essence of the responses may help to identify the most appropriate strategies to provide the highest standards and skills achievements in COVID-19...
ACC 2019 Day 1: PARTNER 3, Evolut Low Risk Trial and Apple Heart Study
17 Mar 2019
Mirvat Al Asnag reports live on three late-breaking trials presented at ACC 2019: PARTNER 3, Evolut Low Risk Trial and the Apple Heart Study
TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome
03 Sep 2025
Aaysha Cader provides her take on TACSI presented by Anders Jeppsson at ESC Congress 2025 in Madrid.
Author
